Evidence-gap map · non-drug interventions

Bipolar Disorder evidence gaps

473 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Bipolar Disorder, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

473registered non-drug trials
73with results posted
76recruiting as of 2026-11-16
93group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Bipolar Disorder by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (22)··51 with results61 with results··12221 with results226·61 with results1
Rehabilitation and therapy services (4)···3··1·····1··1
Mind-body and psychological approaches (122)··10513 with results3634111141 with results473 with results4255 with results221 with results
Cognitive training and education (48)··153 with results122 with results·21 with results31 with results1·41 with results41 with results·124 with results3113 with results4
Diet, fasting and nutrition (21)··38···3·4869·51
Sleep and circadian approaches (9)··16·2···1··5·12
Neuromodulation and electrical stimulation (51)··144 with results285 with results·121 with results1111103 with results257 with results·43 with results2
Oxygen, light, temperature and manual therapies (9)··17·1······6··1
Supplements and nutraceuticals (32)··51 with results112 with results···1··21 with results42 with results121 with results21 with results·91 with results
Other devices and digital tools (3)···1···1···2····
Care delivery and health services (13)···21 with results··1··51 with results··41 with results151 with results1
Other behavioural, not yet classified (186)··143 with results6213 with results131 with results83 with results42 with results·184 with results53 with results71 with results5612 with results132 with results6213 with results344 with results

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Breathing and respiratory training.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 13 trials of care delivery and health services found, none used cognition as a primary outcome (58 trials of other approaches did).
  • Among the 32 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (40 trials of other approaches did).
  • Among the 9 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (40 trials of other approaches did).
  • Among the 48 trials of cognitive training and education found, none used inflammation and other biomarkers as a primary outcome (31 trials of other approaches did).
  • Among the 13 trials of care delivery and health services found, none used inflammation and other biomarkers as a primary outcome (31 trials of other approaches did).
  • Among the 9 trials of sleep and circadian approaches found, none used inflammation and other biomarkers as a primary outcome (31 trials of other approaches did).
  • Among the 9 trials of oxygen, light, temperature and manual therapies found, none used inflammation and other biomarkers as a primary outcome (31 trials of other approaches did).
  • Among the 51 trials of neuromodulation and electrical stimulation found, none used clinical events, survival and healthcare use as a primary outcome (23 trials of other approaches did).
  • Among the 22 trials of exercise and physical activity found, none used clinical events, survival and healthcare use as a primary outcome (23 trials of other approaches did).
  • Among the 21 trials of diet, fasting and nutrition found, none used clinical events, survival and healthcare use as a primary outcome (23 trials of other approaches did).
  • Among the 9 trials of sleep and circadian approaches found, none used clinical events, survival and healthcare use as a primary outcome (23 trials of other approaches did).
  • Among the 9 trials of oxygen, light, temperature and manual therapies found, none used clinical events, survival and healthcare use as a primary outcome (23 trials of other approaches did).
  • Among the 13 trials of care delivery and health services found, none used weight and metabolic markers as a primary outcome (22 trials of other approaches did).
  • Among the 9 trials of sleep and circadian approaches found, none used weight and metabolic markers as a primary outcome (22 trials of other approaches did).

Questions studied but with no results posted

  • Mind-body and psychological approaches × quality of life: 11 trials registered, none with results posted (2 still recruiting)
  • Mind-body and psychological approaches × cognition: 10 trials registered, none with results posted
  • Diet, fasting and nutrition × symptom severity and disease activity: 9 trials registered, none with results posted (7 still recruiting)
  • Diet, fasting and nutrition × mood, anxiety and wellbeing: 8 trials registered, none with results posted (6 still recruiting)
  • Diet, fasting and nutrition × weight and metabolic markers: 8 trials registered, none with results posted (4 still recruiting)
  • Oxygen, light, temperature and manual therapies × mood, anxiety and wellbeing: 7 trials registered, none with results posted (2 still recruiting)
  • Exercise and physical activity × symptom severity and disease activity: 6 trials registered, none with results posted (1 still recruiting)
  • Mind-body and psychological approaches × sleep: 6 trials registered, none with results posted (2 still recruiting)
  • Diet, fasting and nutrition × inflammation and other biomarkers: 6 trials registered, none with results posted (2 still recruiting)
  • Sleep and circadian approaches × mood, anxiety and wellbeing: 6 trials registered, none with results posted
  • Oxygen, light, temperature and manual therapies × symptom severity and disease activity: 6 trials registered, none with results posted (2 still recruiting)
  • Diet, fasting and nutrition × feasibility, adherence and safety: 5 trials registered, none with results posted (3 still recruiting)
  • Sleep and circadian approaches × symptom severity and disease activity: 5 trials registered, none with results posted
  • Mind-body and psychological approaches × heart rate, blood pressure and autonomic: 4 trials registered, none with results posted (1 still recruiting)

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Bipolar Disorder

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 70 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.